Pi-Cardia Overview
- Founded
- 2009
- Status
- Private
- Employees
- 11
- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $27M
- Investors
- 10
Pi-Cardia General Information
Description
Developer of medical catheter technological device intended for the treatment of aortic stenosis. The company's device is a low-profile trans-femoral catheter incorporating unique Nitinol elements to create fractures in valve calcifications without injuring the surrounding soft tissues, thereby allowing doctors to monitor and increase the valve's orifice area eliminating the need for replacement.
Contact Information
Website
Formerly Known As
Pi R Squared
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Primary Office
- 10 Plaut Street
- Science Park
- Rehovot 7670609
- Israel
+972 00-000-0000
Pi-Cardia Timeline
Pi-Cardia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 20-Apr-2020 | $27M | 000.00 | Completed | Clinical Trials - General | |
| 6. Later Stage VC | 10-Sep-2019 | 000.00 | Completed | Clinical Trials - General | ||
| 5. Later Stage VC (Series C) | 07-Jan-2016 | 0000 | 000.00 | 000.00 | Completed | Pre-Clinical Trials |
| 4. Later Stage VC (Series B) | 21-Sep-2015 | 00.000 | 00.000 | 000.00 | Completed | Pre-Clinical Trials |
| 3. Later Stage VC | 05-Aug-2014 | 00.00 | 00.000 | 00.00 | Completed | Generating Revenue |
| 2. Early Stage VC | 28-Jun-2012 | $1.67M | $1.67M | 00.00 | Completed | Startup |
| 1. Early Stage VC (Series A) | 21-Dec-2011 | Completed | Startup |
Pi-Cardia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Dummy | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 | ||
| Preferred C1 | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 0.00 | ||
| Preferred C | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 | ||
| Preferred B | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | ||
| Preferred B1 | 250,000 | $1.24 | $1.24 | 1x | $1.24 | 1.75% | ||
| Preferred A | 600,000 | $1 | $1 | 1x | $1 | 4.19% |
Pi-Cardia Executive Team (5)
Pi-Cardia Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Irit Yaniv MD | Accelmed | Board Member | 000 0000 |
| Jacques Seguin Ph.D | Self | Chairman | 000 0000 |
| Ofer Goldberg | Clal Biotechnology Industries | Board Member | 000 0000 |
Pi-Cardia Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPi-Cardia Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Jacques Séguin | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Sofinnova Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| JVC Investment Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Anatomy Medical Technology Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| VI Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |